Efficacy of ciclesonide versus fluticasone propionate in patients with mild to moderate asthma (12 to 75 y) (BY9010/M1-142)

Study identifier:BY9010/M1-142

ClinicalTrials.gov identifier:NCT00163423

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Comparison of Ciclesonide (80 mcg Once Daily in the Evening) and Fluticasone propionate (100 mcg Twice Daily) in Patients with Mild to Moderate Asthma

Medical condition

asthma

Phase

Phase 3

Healthy volunteers

No

Study drug

Ciclesonide

Sex

All

Actual Enrollment

480

Study type

Interventional

Age

12 Years - 75 Years

Date

Study Start Date: 01 Nov 2004
Primary Completion Date: 01 Jan 2006
Study Completion Date: 01 Jan 2006

Study design

Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Dec 2016 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria